HSR26-229: Efficacy and Safety of Immune Checkpoint Inhibitors Compared to Chemotherapy and Radiotherapy Alone in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis of Reconstructed Time-to-Event Data from Randomized Controlled Trials